このエントリーをはてなブックマークに追加


ID 65538
FullText URL
Author
Hirai, Ryosuke Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Hirai, Mami Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID
Otsuka, Motoyuki Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Mitsuhashi, Toshiharu Center for Innovative Clinical Medicine, Okayama University Hospital
Shimodate, Yuichi Department of Gastroenterology and Hepatology, Kurashiki Central Hospital
Mouri, Hirokazu Department of Gastroenterology and Hepatology, Kurashiki Central Hospital
Matsueda, Kazuhiro Department of Gastroenterology and Hepatology, Kurashiki Central Hospital
Yamamoto, Hiroshi Department of Gastroenterology and Hepatology, Kurashiki Central Hospital
Mizuno, Motowo Department of Gastroenterology and Hepatology, Kurashiki Central Hospital
Abstract
Background We previously demonstrated that the Kyoto classification of gastritis was useful for judging the status of Helicobacter pylori infection in a population-based screening program, and that adding H. pylori antibody test improved its accuracy (UMIN000028629). Here, we tested whether our endoscopic diagnosis of H. pylori infection status reliably estimated gastric cancer risk in the program.
Methods Data were collected from1345 subjects who underwent endoscopic follow-up 4 years after the end of the registration. We analyzed the association of three diagnostic methods of H. pylori infection with gastric cancer detection: (1) endoscopic diagnosis based on the Kyoto classification of gastritis; (2) serum diagnosis according to the ABC method (H. pylori antibody and pepsinogen I and II); and (3) endoscopic diagnosis together with H. pylori antibody test.
Results During the follow-up, 19 cases of gastric cancer were detected. By Kaplan–Meier analysis, the detection rates of cancer were significantly higher in the past or current H. pylori infection groups than in the never-infected group with all 3 methods. By the Cox proportional hazards model, the hazard ratio for cancer detection was highest in evaluation with the combined endoscopic diagnosis and the antibody test (method 3; hazard ratio 22.6, 95% confidence interval 2.99–171) among the three methods (the endoscopic diagnosis (method 1); 11.3, 2.58–49.8, and the ABC method (method 2); 7.52, 2.49–22.7).
Conclusions Endoscopic evaluation of H. pylori status with the Kyoto classification of gastritis, especially combined with serum anti-Helicobacter pylori antibody testing, reliably risk-stratified subjects in a population-based gastric cancer screening program.
Keywords
Cancer screening
Gastric cancer
Helicobacter pylori
Gastrointestinal endoscopy
Atrophic gastritis
Note
The version of record of this article, first published in Journal of Gastroenterology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s00535-023-02010-w
Published Date
2023-06-21
Publication Title
Journal of Gastroenterology
Volume
volume58
Issue
issue9
Publisher
Springer Science and Business Media LLC
Start Page
848
End Page
855
ISSN
0944-1174
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© The Author(s) 2023
File Version
publisher
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1007/s00535-023-02010-w
License
http://creativecommons.org/licenses/by/4.0/
Citation
Hirai, R., Hirai, M., Otsuka, M. et al. Endoscopic evaluation by the Kyoto classification of gastritis combined with serum anti-Helicobacter pylori antibody testing reliably risk-stratifies subjects in a population-based gastric cancer screening program. J Gastroenterol 58, 848–855 (2023). https://doi.org/10.1007/s00535-023-02010-w